Enhancing progestin therapy with a glucagon-like peptide 1 agonist for the conservative management of endometrial cancer

Authors

Andrea R Hagemann, Washington University School of Medicine in St. Louis
Ian S Hagemann, Washington University School of Medicine in St. Louis
David G Mutch, Washington University School of Medicine in St. Louis
Eric J Devor, University of Iowa
Paige K Malmrose, University of Illinois at Chicago
Yuping Zhang, University of Iowa
Abigail M Morrison, University of Iowa
Kristina W Thiel, University of Iowa
Kimberly K Leslie, University of New Mexico

Journal

Cancers

Publication Date

2-10-2025

Volume

17

Issue

4

First Page

598

Document Type

Open Access Publication

DOI

10.3390/cancers17040598

Rights and Permissions

Hagemann AR, Hagemann IS, Mutch DG, Devor EJ, Malmrose PK, Zhang Y, Morrison AM, Thiel KW, Leslie KK. Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer. Cancers (Basel). 2025 Feb 10;17(4):598. doi: 10.3390/cancers17040598 Copyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/ licenses/by/4.0/).

Recommended Citation

Hagemann, Andrea R; Hagemann, Ian S; Mutch, David G; Devor, Eric J; Malmrose, Paige K; Zhang, Yuping; Morrison, Abigail M; Thiel, Kristina W; and Leslie, Kimberly K, "Enhancing progestin therapy with a glucagon-like peptide 1 agonist for the conservative management of endometrial cancer." Cancers. 17, 4. 598 (2025).
https://digitalcommons.wustl.edu/oa_4/4885

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.